The MACSPlex analysis revealed patient-specific differences with signal from immune/inflammation-related and epithelial (CTCs) cells, as well as cancer-related markers (CD24, CD29, CD44, and CD146), which represent a valuable source of information to further understand the mechanisms of cancer biology in brain metastases. This evidence concerns the gene MCAM and cancer.